Implications of the European Association for the Study of Obesity's New Framework Definition of Obesity: Prevalence and Association With All-Cause Mortality.

Dicker D, Karpati T, Promislow S, Reges O

Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.

Wolff Sagy Y, Ramot N, Battat E, Arbel R, Reges O, Dicker D, Lavie G

Publisher Correction: Long-Term Effects of Professional and Non-Professional Support on a Healthy Lifestyle Following Bariatric Surgeries.

Ofri L, Barak S, Dicker D, Blau A

Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels.

Çalık Başaran N, Dotan I, Dicker D

Introduction Long-Term Effects of Professional and Non-professional Support on a Healthy Lifestyle Following Bariatric Surgeries.

Ofri L, Barak S, Dicker D, Blau A

Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study.

Zloof Y, Nitecki M, Simchoni M, Adar O, Tsur AM, Derazne E, Tzur D, Rotschield J, Braun M, Pinhas-Hamiel O, Fliss Isakov N, Milloh-Raz H, Nemet D, Dicker D, Moyal A, Scheuerman O, Beer Z, Braun M, Afek A, Gerstein HC, Batty GD, Chodick G, Twig G

Treatment of hospitalized patient with hyperglycemia: An EFIM critically appraised and adapted guideline.

Uyaroğlu OA, Ruza I, Skrha J, Patoulias D, Bevc S, Bojadjiev BI, Gómez-Huelgas R, Bojunga J, Lesniak W, Carretero-Gómez J, Wacker J, Pérez-Belmonte LM, Dicker D, Petreski T, Marín-León I

Metformin continuation post-metabolic bariatric surgery and relapse of diabetes.

Dicker D, Pinto D, Reges O

Metabolic Bariatric surgery in People with Obesity aged ≥65 Years.

Çalık Başaran N, Marcoviciu D, Dicker D

Obesity management in the older age, new understanding for old challenges".

Dicker D, Çalık Başaran N, Yumuk VD

International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Cohen RV, Busetto L, Levinson R, Le Roux CW, Salminen P, Prager G, International Consensus on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.

European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity

Publisher Correction: EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.

European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.

Verma S, Colhoun HM, Dicker D, Hovingh GK, Kahn SE, Kautzky-Willer A, Lingvay I, Plutzky J, Rasmussen S, Rathor N, Hoff ST, Lincoff AM

Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway.

Allen JE, Krigsfeld G, Patel L, Mayes PA, Dicker DT, Wu GS, El-Deiry WS